GPs Alerted 5 Million Times in the Last Year to Recommend Self-Care Rather than Write a Prescription

First DatabankGPs and other prescribers have been prompted more than 5 million times in the last 12 months to encourage patients to take action to look after themselves, rather than relying on medication from their doctor.

A national analysis of how practices in two thirds of England’s CCGs use a prescribing decision support technology called OptimiseRx found that thousands of professionals had been acting on the alerts, helping prescribers to comply with self-care prescribing guidelines from NHS England. Published in April 2018, the guidance recommends that practices should promote self-care when appropriate to reduce costs, discouraging prescriptions for medications such as vitamin and mineral supplements, antifungal treatments, and laxatives for minor illnesses.

The news follows the finding last year that GPs across the country had saved at least £100m by responding to alerts to prescribe alternative and lower cost medicines for patients.

The technology works in practice by enabling the presentation of NHS prescribing guidance and alerting GPs,at the point of prescribing, in their existing clinical IT system when over counter medicines should not be routinely prescribed, and where self-care is more appropriate.

Analysis conducted between April 2018 to the end of March 2019 showed that5 million such alerts were sent to prescribers, resulting in avoided costs to the NHS of over £10 million. This is helping to achieve NHS Long Term Plan ambitions of reducing prescribing costs by more than £200m a year and is helping to tackle wider national priorities such as over-prescribing.

NHS England’s 2018 guidance also looked to reduce the use of medications with limited clinical evidence, such as probiotics. It also highlighted NHS England-funded medicines that should be referred to secondary care, for conditions including cancer and cystic fibrosis, which are not to be prescribed in primary care. By using OptimiseRx to comply with the guidance, GPs have in total saved more than £10m in the last year alone.

The technology has traditionally been used to help GPs make decisions that comply with local and national prescribing priorities. This includes alerting doctors when more cost-effective alternatives are available, and by providing patient-specific prescribing recommendations based on the patient’s record.

Darren Nichols, Managing Director, FDB comments: "By working with practices across the country, we recognise the need for accurate, actionable information when prescribing decisions are being made. Using technology to remind GPs of ever evolving prescribing policy, including that around self-care and appropriate medication decisions, and ensuring that this is patient-specific, means that practice prescribers can rapidly access information that is appropriate for their patients. They can then make informed prescribing decisions that benefit the patient and the practice.From just one year's worth of data, we can see the tremendous impact that such information can have."

NHS England’s 2018 guidance can be found at https://www.england.nhs.uk/medicines/conditions-for-which-over-the-counter-items-should-not-routinely-be-prescribed/

About FDB

FDB (First Databank), part of the Hearst Health network, is the leading provider of drug knowledge that helps healthcare professionals make precise decisions. With thousands of customers worldwide, FDB enables our information system developer partners to deliver valuable, useful, and differentiated solutions. We offer four decades of experience in transforming medical knowledge into actionable, targeted, and effective solutions that help improve patient safety, operational efficiency, and healthcare outcomes.

About FDB OptimiseRx

FDB OptimiseRx®is the leading medicines optimisation solution for primary care in the UK. OptimiseRx combines evidence-based best practice, safety and cost-effective prescribing messages, and delivers them in real time at the point of care during the prescribing workflow.

Used across more than 60% of NHS Clinical Commissioning Groups (CCGs) and Health Boards and thousands of GP practices, OptimiseRx is trusted and valued by prescribers. OptimiseRx is the only solution that delivers patient-specific prescribing guidance, integrated with prescribing workflows, supporting medicines optimisation at the point of care in EMIS Web, TPP SystmOne and Microtest Evolution. Tailored to the patient medical record, OptimiseRx takes into consideration current and previous medications, morbidities, observations and measurements to support prescribers to make the safest, most clinically appropriate prescribing decision.

Most Popular Now

Open Call HORIZON-HLTH-2021-TOOL-06-03: …

This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination 5 "Unlocking the full potential of new tools, technologies and digital...

CSAM Acquires Optima - Further Boosts eH…

CSAM Health Group AS ("CSAM"), the leading provider of niche eHealth solutions in the Nordics, today announced it has signed a deal to acquire eHealth player Optima Corporation Ltd from...

Novartis and Hewlett Packard Enterprise …

Novartis and Hewlett Packard Enterprise (HPE)announced a collaboration that aims to accelerate the use of data and digital technologies within Novartis efforts to reimagine global health and improve access to...

COVID-19 Origins Still a Mystery

Scientists using computer modelling to study SARS-CoV-2, the virus that caused the COVID-19 pandemic, have discovered the virus is most ideally adapted to infect human cells - rather than bat...

Using Artificial Intelligence to Overcom…

Depression is a worldwide problem, with serious consequences for individual health and the economy, and rapid and effective screening tools are thus urgently needed to counteract its increasing prevalence. Now...

Deep Machine Learning Completes Informat…

The Structural Bioinformatics and Network Biology laboratory, led by ICREA Researcher Dr. Patrick Aloy, has completed the bioactivity information for a million molecules using deep machine-learning computational models. It has...

EU Digital COVID Certificate Enters into…

The EU Digital COVID Certificate Regulation enters into application. This means that EU citizens and residents will now be able to have their Digital COVID Certificates issued and verified across...

Philips and the Spanish National Center …

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has participated in an important research project to develop a magnetic resonance (MR) imaging technique [1,2] that could...

Scottish Health and Care Professionals G…

Scottish health and care professionals across a wide range of clinical settings including NHS Scotland health boards are being given access to an individual's COVID-19 vaccine status through the Orion...

Ethics and Governance of Artificial Inte…

Artificial Intelligence (AI) refers to the ability of algorithms encoded in technology to learn from data so that they can perform automated tasks without every step in the process having...

It's Going to be Quite a Handover…

Health and social care secretary Matt Hancock has been abruptly replaced by Sajid Javid. The Highland Marketing advisory board consider the huge agenda he is now facing, and what it...

Philips Accelerates Stroke Diagnosis and…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced a strategic partnership agreement with NICO.LAB, a MedTech stroke care company. Together with the recently expanded stroke...